Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis

Journal of Infection

Volumn 71, Issue 5, 2015, Pages 526-533

  Petruccioli, Elisa ^a   Petrone, Linda ^a   Vanini, Valentina ^a   Cuzzi, Gilda ^a   Navarra, Assunta ^a   Gualano, Gina ^a   Palmieri, Fabrizio ^a   Girardi, Enrico ^a   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Biomarker; CD27; Diagnosis; LTBI; Tuberculosis

Indexed keywords

CD27 ANTIGEN; GAMMA INTERFERON; BACTERIAL ANTIGEN; BIOLOGICAL MARKER; CD45 ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL EVALUATION; DEMOGRAPHY; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LATENT TUBERCULOSIS; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE SUBPOPULATION; BLOOD; GENETICS; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; YOUNG ADULT;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD27; ANTIGENS, CD45; BIOMARKERS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

EID: 84945462971     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.07.009     Document Type: Article

References (58)

1. WHO Global tuberculosis report 2014, WHO Global TB Report 2014.
2. Verweij K.E., Kamerik A.R., van Ingen J., van Dijk J.H., Sikwangala P., Thuma P., et al. Application of modern microbiological diagnostic methods for tuberculosis in Macha, Zambia. Int J Tuberc Lung Dis 2010, 14:1127-1131.
3. Lagrange P.H., Thangaraj S.K., Dayal R., Deshpande A., Ganguly N.K., Girardi E., et al. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One 2013, 8:e73579.
4. Xia H., Wang X., Li F., Longuet C., Vernet G., Goletti D., et al. Diagnostic values of the QuantiFERON-TB gold in-tube assay carried out in China for diagnosing pulmonary tuberculosis. PLoS One 2015, 10:e0121021.
5. Sester M., Sotgiu G., Lange C., Giehl C., Girardi E., Migliori G.B., et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011, 37:100-111.
6. Goletti D., Sanduzzi A., Delogu G. Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl 2014, 91:24-31.
7. Goletti D., Sester M. Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regions. Expert Rev Mol Diagn 2012, 12:231-234.
8. Delogu G., Chiacchio T., Vanini V., Butera O., Cuzzi G., Bua A., et al. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 2011, 6:e18315.
9. Goletti D., Butera O., Vanini V., Lauria F.N., Lange C., Franken K.L., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 2010, 36:135-142.
10. Goletti D., Raja A., Ahamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010, 61:133-143.
11. Goletti D., Parracino M.P., Butera O., Bizzoni F., Casetti R., Dainotto D., et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 2007 Jan 27, 8:5.
12. Goletti D., Carrara S., Butera O., Amicosante M., Ernst M., Sauzullo I., et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-study. PLoS One 2008, 3:e3417.
13. Jafari C., Ernst M., Kalsdorf B., Greinert U., Diel R., Kirsten D., et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006, 174:1048-1054.
14. Chiacchio T., Petruccioli E., Vanini V., Butera O., Cuzzi G., Petrone L., et al. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011, 6:e27539.
15. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., et al. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 2010, 16:1282-1284.
16. Sargentini V., Mariotti S., Carrara S., Gagliardi M.C., Teloni R., Goletti D., et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009, 9:99.
17. Chegou N.N., Black G.F., Kidd M., van Helden P.D., Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009, 9:21.
18. Dosanjh D.P., Bakir M., Millington K.A., Soysal A., Aslan Y., Efee S., et al. Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLoS One 2011, 6(12):e28754.
19. Kabeer B.S., Raja A., Raman B., Thangaraj S., Leportier M., Ippolito G., et al. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 2011, 11:135.
20. Harari A., Rozot V., Enders F.B., Perreau M., Stalder J.M., Nicod L.P., et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17:372-376.
21. Vanini V., Petruccioli E., Gioia C., Cuzzi G., Orchi N., Rianda A., et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 2012, 65:49-59.
22. Petruccioli E., Petrone L., Vanini V., Sampaolesi A., Gualano G., Girardi E., et al. IFNgamma/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013, 66:475-486.
23. Pollock K.M., Whitworth H.S., Montamat-Sicotte D.J., Grass L., Cooke G.S., Kapembwa M.S., et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis 2013, 208:952-968.
24. Rozot V., Patrizia A., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., et al. Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis 2015, 60:432-437.
25. Rozot V., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 2013, 43:1568-1577.
26. Sutherland J.S., Adetifa I.M., Hill P.C., Adegbola R.A., Ota M.O. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009, 39:723-729.
27. Day C.L., Abrahams D.A., Lerumo L., Janse van Rensburg E., Stone L., O'rie T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011, 187:2222-2232.
28. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di Carlo P., Titone L., et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40:2211-2220.
29. Caccamo N., Guggino G., Meraviglia S., Gelsomino G., Di Carlo P., Titone L., et al. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 2009, 4:e5528.
30. Sallusto F., Lanzavecchia A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 2009, 39:2076-2082.
31. Appay V., van Lier R.A., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytom A 2008, 73:975-983.
32. Mahnke Y.D., Brodie T.M., Sallusto F., Roederer M., Lugli E. The who's who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol 2013, 43:2797-2809.
33. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat Rev Immunol 2003, 3:609-620.
34. Croft M. The TNF family in T cell differentiation and function-unanswered questions and future directions. Semin Immunol 2014, 26:183-190.
35. Goletti D., Butera O., Bizzoni F., Casetti R., Girardi E., Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-992.
36. Butera O., Chiacchio T., Carrara S., Casetti R., Vanini V., Meraviglia S., et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis 2009, 9:182.
37. Wang X., Cao Z., Jiang J., Niu H., Dong M., Tong A., et al. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect 2010, 60:133-139.
38. Nikitina I.Y., Kondratuk N.A., Kosmiadi G.A., Amansahedov R.B., Vasilyeva I.A., Ganusov V.V., et al. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans. PLoS One 2012, 7:e43733.
39. Portevin D., Moukambi F., Clowes P., Bauer A., Chachage M., Ntinginya N.E., et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 2014, 14:931-938.
40. Schuetz A., Haule A., Reither K., Ngwenyama N., Rachow A., Meyerhans A., et al. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One 2011, 6:e27284.
41. Streitz M., Fuhrmann S., Thomas D., Cheek E., Nomura L., Maecker H., et al. The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection. Cytom B Clin Cytom 2012, 82:360-368.
42. Streitz M., Tesfa L., Yildirim V., Yahyazadeh A., Ulrichs T., Lenkei R., et al. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis. PLoS One 2007, 2:e735.
43. Geldmacher C., Ngwenyama N., Schuetz A., Petrovas C., Reither K., Heeregrave E.J., et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010, 207:2869-2881.
44. Lyadova I.V., Oberdorf S., Kapina M.A., Apt A.S., Swain S.L., Sayles P.C. CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol 2004, 138:21-29.
45. Kapina M.A., Shepelkova G.S., Mischenko V.V., Sayles P., Bogacheva P., Winslow G., et al. CD27 low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection. J Immunol 2007, 178:976-985.
46. Wieland C.W., Kerver M.E., Florquin S., Nolte M.A., Borst J., van Lier R., et al. CD27 contributes to the early systemic immune response to Mycobacterium tuberculosis infection but does not affect outcome. Int Immunol 2006, 18:1531-1539.
47. Jiang J., Wang X., Wang X., Cao Z., Liu Y., Dong M., et al. Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis. J Clin Immunol 2010, 30:566-573.
48. Roederer M., Nozzi J.L., Nason M.C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytom A 2011, 79:167-174.
49. Griner P.F., Mayewski R.J., Mushlin A.I., Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981, 94:557-592.
50. Metz C.E. Basic principles of ROC analysis. Semin Nucl Med 1978, 8:283-298.
51. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
52. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
53. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
54. Fritsch R.D., Shen X., Sims G.P., Hathcock K.S., Hodes R.J., Lipsky P.E. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005, 175:6489-6497.
55. Chiacchio T., Petruccioli E., Vanini V., Cuzzi G., Pinnetti C., Sampaolesi A., et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 2014, 69:533-545.
56. Adekambi T., Ibegbu C.C., Cagle S., Kalokhe A.S., Wang Y.F., Hu Y., et al. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest 2015, 125:1827-1838.
57. Kalina T., Flores-Montero J., van der Velden V.H., Martin-Ayuso M., Bottcher S., Ritgen M., et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012, 26:1986-2010.
58. Baker M. Reproducibility crisis: blame it on the antibodies. Nature 2015, 521:274-276.